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Abstract 
A new pyrimidine based ‘NNO’ tridentate ligand 2,4-dihydroxyacetophenone-4,6-
dimethyhydrazino pyrimidine (H2MHyP) (complex I)  has been synthesized and characterized by 
elemental analyses, mass, IR 
1
H NMR spectra and X-ray crystallographic studies. The 
Coordination mode of the synthesized ligand has been established by solid state isolation and 
physico-chemical identification of Co(III) and Cu(II) complexes, [Co(HMHyP)2]Cl (complex II), 
[Co(HMHyP)2]Br (complex III) and [Cu(HMHyP)]NO3 (complex IV)  respectively. All the 
reported coordination complexes are 1:1 electrolytic cationic species and the ligand behaves as a 
monodeprotonated ‘NNO’ tridentate one in all the complex species. IR spectral data indicate that 
the coordination of each of the metal centre of the complexes occurs through the pyrimidine 
nitrogen, azomethine nitrogen and hydroxyl oxygen atoms. X-ray crystallographic data have 
authenticated a CoN4O2 octahedral coordination for II and III (Triclinic (P-1) and Monoclinic   
(P21/n), respectively) and a CuN2O2 square planar coordination for IV (Triclinic (P-1)). All the 
synthesized compounds were tested for their DNA binding abilities and their mode of binding with 
DNA. Compounds II, III & IV show potential DNA binding activities with Salmon Testis DNA. 
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1. Introduction 
 
Bioinorganic chemistry is a fast developing field of modern chemistry that uses Schiff bases  and 
their transition metal complexes for a variety of applications, e.g. in biological, medical, and 
environmental sciences [1]. The Schiff base ligands are quite popular because they are easily 
prepared by the condensation between carbonyl compounds and amines and also have some 
biochemical and analytical importance [2]. Hydroxy acetophenone can be used as primary 
compound for the synthesis of chalcones [3], flavones [4] etc. Schiff bases of Hydroxy aldehydes 
or, ketones are extensively used as coordinating ligands for the synthesis of metal complexes. Over 
the past decade, the syntheses of therapeutically active heterocyclic molecules have become one of 
the main areas of interest in synthetic chemistry [5]. These important structures have gained much 
consideration, because they are potentially active ligands and as well as of their binding capability 
towards various biological targets. Among these heterocycles, pyrimidines and their derivatives 
show various biochemical and agricultural applications [6]. Uracil (2,4-dihydroxypyrimidine) and 
thiamine (5-methyluracil) have immense importance in metabolism because  these derivatives are 
basic units for RNA and DNA [7]. Pyrimidine ring systems in nucleic acids, vitamins and co-
enzymes have some effective binding sites for metal ions. The presence of more than one hetero 
atom and the higher π acidity of the pyrimidine rings as compared to that of pyridine bases play an 
important role in coordination chemistry, and also serve as a better model in biological systems [8-
10].  
 In the present communication, we have reported the syntheses, spectral and structural 
characterizations of a new NNO tridentate Schiff base ligand (H2MHyP) using 2-hydrazino-4,6-
dimethylpyrimidine and substituted acetophenone and its Co(III) and Cu(II) complexes. The 
  
details of DNA binding activities and mode of DNA binding of these complexes have also been 
reported. 
 
2.  Experimental 
2.1    Reagents and instrumentation 
All the reagents used were of AR grade and obtained from commercial sources and used without 
purification. Sodium salt of Salmon Testis DNA was purchased from Sigma-Aldrich. Spectrograde 
solvents were used for spectral measurements. Elemental analyses (C, H and N) were done with a 
Perkin-Elmer 2400 CHNS/O analyzer. The cobalt and copper contents of the complexes were 
determined gravimetrically as anhydrous CoSO4 and iodometrically, respectively. Electronic 
spectra were recorded on a Shimadzu UV-2401PC spectrophotometer. IR spectra (4000–450 cm-1) 
were recorded on a Perkin-Elmer L120-000A FT-IR spectrophotometer with KBr pellets. The 
molar conductance of the complexes in methanol were measured with a Systronics 304 digital 
conductivity meter.  
1
H NMR spectrum of the ligand was recorded in DMSO-d6 with a Bruker AC 
400 superconducting FT NMR. High resolution mass spectroscopy (HRMS) was performed with a 
waters XEVO G2-S QTof mass spectrometer. A Rigaku FR-X Ultrahigh Brilliance Micro focus 
RA generator and Rigaku XtaLAB P200 system diffractometer was used to collect X-ray data of 
the complexes. Fluorescence measurements were done with a Perkin Elmer LS 55 Fluorescence 
spectrometer. Viscosity measurements were done with a Brookfield DV-II + Pro v6.3 Viscometer. 
 
2.2 . Syntheses 
 
2.2.1. Synthesis of the ligand, H2MHyP (Compound I)  
2,4-dihydroxyacetophenone-4,6-dimethyhydrazino pyrimidine, H2MHyP [Fig. 1] was synthesized 
by refluxing an eqimolar mixture of 4,6-dimethyl-2-hydrazinopyrimidine [11-12] and 2,4-
  
dihydroxyacetophenone in dry ethanol involving conversion of dihydroxy acetophenone into its 
hydrazino pyrimidine derivative. A red crystalline solid was obtained after slow evaporation of the 
solvent. Crystals suitable for X-ray diffraction were obtained on slow evaporation of the 
compound I in ethanol. Yield of ca. 70–75% (m.p.: 182-183°C). Anal. Calcd for C14H16N4O2: C, 
61.7; H, 5.9; N, 20.6. Found: C, 60.8; H, 5.5; N, 19.8%. IR (KBr)  (cm-1) : 1625 (CH=N), 3432 
(C-OH). 
1
H NMR (DMSO-d6) δ (ppm): 13.55 (1H, C10-OH), 10.46 (1H, C8-OH), 9.66 (1H, NH- 
hydrazine), 6.67 (1H, pyrimidine), 2.31(6H, 2-CH3 pyrimidine), 2.26 (3H, C5-CH3). HRMS m/z: 
Calcd. for C14H17N4O2 [M+H]
+
 273.136, found 272.1358. 
 
2.2.2 Syntheses of complexes  II and III  
The reported Co(III) complexes have been prepared by refluxing ethanolic solution of the title 
ligand (I) (1.05mM) and CoCl2.6H2O or CoBr2.6H2O (0.525mM) in water bath for ~1 hr in 
presence of air. Dark brown coloured solution in both the cases, were obtained. On slow 
evaporation of the resulting solutions, the desired Co(III) complex, in each case, was separated out. 
The dark brown solids, in both the cases were filtered off, washed with cold ethanol and dried over 
anhydrous CaCl2. Dark red crystals, in both the cases, were obtained from ethanol/ hexane mixture 
by slow diffusion, found suitable for X-ray crystallography. Anal. Calcd for C28H32N8O5CoCl (II): 
C, 51.3; H, 4.9; N, 17.1; Co, 8.9. Found: C, 50.9; H, 4.3; N, 16.8; Co, 8.8%.  IR (KBr)  (cm-1): 
1637 (CH=N), 3515 (C-OH). UV–Visible (DMSO, λmax,  nm): 634 ( 
1 
A1g→
3
T2g), 375 (
1
A1g  →
1 
T1g ), 
325(1 A1g →
1 
T2g
 
), 265 (n→ π*), 219 (π→ π*). DRS (λmax, nm):  653 (
1
A1g→
3
T2g), 412 (
1
A1g →
1
T1g), 
378 (
1
A1g →
1
T2g). 
1
H NMR (DMSO-d6) δ (ppm): 13.06 (1H, OH), 9.654 (1H, NH- hydrazine), 
2.506 (6H, 2-CH3, pyrimidine), 2.27 (3H, C5-CH3). HRMS m/z: Calcd. for C28H30N8O4Co [M-Cl]
+
 
601.14, found 601.1713.  
  
Anal. Calcd for C30H36N8O5CoBr (III):  C, 49.5; H, 4.9; N, 15.4; Co, 8.1. Found: C, 48.8; H, 4.5; 
N, 14.9; Co, 7.9%. IR (KBr)  (cm-1):  1639 (CH=N), 3497 (C-OH). UV–Visible (DMSO, λmax, nm) : 
633 (
1
A1g→
3
T2g), 365 (
1
A1g  →
1 
T1g ), 310 (
1 
A1g →
1 
T2g
 
), 265 (n → π*), 220 (π→ π* ). DRS (λmax, 
nm): 650 (
1
A1g→
3
T2g), 410 (
1
A1g →
1
T1g), 376 (
1
A1g →
1
T2g). 
1
H NMR (DMSO-d6) δ (ppm): 13.0 
(1H, OH), 9.52 (1H, NH-hydrazine), 2.504 (6H, 2-CH3, pyrimidine), 2.23 (3H, C5-CH3).  HRMS 
m/z: Calcd. for C28H30N8O4Co [M-Br]
+
  601.19, found 601.1763.  
 
2.2.3 Synthesis of compound IV 
The Cu(II) complex reported here, has been prepared by refluxing an equimolar (1.05mM) mixture 
of (I) and Cu(NO3)2.3H2O in ethanol for ~1hr. in a water bath. On slow evaporation of the 
resulting solution, reddish crystalline solids separated out, were filtered off, washed with cold 
ethanol and dried over anhydrous CaCl2. Red brown crystals obtained from acetone/ hexane 
mixture were found to be suitable for X-ray diffraction. Anal. Calcd for C14H21CuN5O8: C, 37.3; 
H, 4.7; N, 15.5; Cu, 14.1. Found: C, 36.9; H, 4.3; N, 15.2; Cu, 13.8%. IR (KBr)  (cm-1):  1611 
(CH=N). UV–Visible (DMSO, λmax, nm): 650 (
2
B1g →
2
A1g). DRS (λmax. nm): 600 [B2(xy) → A1(x
2
-
y
2
)]. HRMS m/z: Calcd. for C14H15N4O2Cu [M-(NO3+H2O)]
+
 =334.66, found 334.0493.  
 
2.3 Single crystal X-ray diffraction study   
 
Data for compounds I to IV were collected on a Rigaku FR-X Ultrahigh Brilliance Micro focus 
RA generator /confocal optics and Rigaku XtaLAB P200 system with Mo-Kα radiation (λ = 
0.71073 Å). Intensity data were collected using ω steps accumulating area detector images 
spanning at least a hemisphere of reciprocal space. All data were corrected for Lorentz polarization 
effects. A multi-scan absorption correction was applied using Crystal Clear [13]. Structures were 
  
solved by direct methods (SIR 2004 [14] or SIR 2011 [15]) and refined by full-matrix least-squares 
against F
2
 (SHELXL-2013 [16]). All hydrogen atoms were assigned riding isotropic displacement 
parameters and constrained to idealize geometries, except those bound to N or O, which were 
located from the difference Fourier map and refined subject to a distance restraint. Hydrogen 
atoms could not be located for one of the water solvent molecules in IV. Neutral atom scattering 
factors were taken from International Tables for Crystallography (IT), Vol. C, Table 6.1.1.4 [17]. 
Anomalous dispersion effects were included in Fcalc [18]. All calculations were performed using 
the Crystal Structure [19] interface, and figures were drawn using OLEX2 [20]. 
 
2.4 DNA binding study  
2.4.1. UV-Visible spectroscopic Study 
The spectrophotometric studies were performed at 30
o
C in Shimadzu (UV-2401PC) 
spectrophotometer using 1 cm path length rectangular quartz cuvette. To monitor the changes in 
absorption spectrum of DNA due to addition of complex II, III and IV, all of them was added 
gradually in each of the sample (containing DNA) and reference cuvettes. The absorbance of each 
complex (due to scattering) was systematically neglected by the addition of the same amount of 
complex in both suspensions of the cuvettes. Thereby, contribution due to scattering of compounds 
in DNA spectra was automatically nullified.  
The interaction of the complex with the DNA was analyzed by the famous Hill equation [21] 
This is stated below, Log (Z / (1-Z)) = Y Log Kb+ Y Log [Cf]----------------------[1], 
Where, Z=(A0-Ai)/(A0-Af) where, where A0 is the (absorbance) 260 nm of DNA in the absence of 
complex, Ai the (absorbance) 260 nm of DNA at any complex concentration, and Af the 
(absorbance) 260 nm of DNA at complex concentration for which interaction met saturation. Cf 
  
and Kb were the free complex concentration and binding constant respectively. Moreover, Y is the 
co-operativity of the interaction of complex with respect to the DNA. The value as well sign both 
were important for the determination of the binding nature of the interaction. From the slope, the Y 
could be calculated which, was further used to determine the Binding constant using intercept of 
the equation.  The importance of Y was that it characterized nature of co-operativity, that is, Y <1 
signified negative co-operative nature of binding, Y = 1 signified non-co-operative nature of 
binding, and Y > 1 signified positive co-operative nature of binding [21]. 
 
2.4.2. Spectrofluorimetric study 
The fluorescence quenching measurements were done by using Perkin Elmer LS 55 Fluorescence 
spectrometer. Both the compounds as well as free DNA have no characteristic fluorescence. But 
intercalation of EB increased the fluorescence intensity which was used to observe the binding 
behavior of DNA with respect to the compounds. The said Salmon Testis DNA were prepared in 
sterile Tris buffer (50 mM, pH 7.5) of 1mg/ ml stock by mild sonication at 4
0
C in presence of ice, 
so that the linear DNA was broken into uniform size. Further the DNA was incubated with 
saturating amount of EB (10 mg/ ml in sterile water) in dark for another 30 mins where, complete 
intercalation of EB took place. Now the EB–DNA was excited at 480 nm and the emission was 
monitored in between 500 to 700 nm with an emission maximum at around 600 nm. The emission 
slit width (10 nm) and scan rate (200 nm /min) were kept constant for all the measurements.  
In order to demonstrate the measure of the threshold DNA concentration and the binding constants, 
the fluorescence data were further analyzed according to the simplified form of the Scatchard 
equation [22]: 
r/Cf ＝ Kb(1－nr) ------------------------[2] 
  
The Scatchard equation was plotted to measure the binding constant between bio-macromolecule 
and compounds. Where, r＝ Cb/CDNA, Cb＝Ct－Cf. Cf, Cb and Ct are the compounds 
concentrations of free form, bound form and the total form respectively, Kb is the binding constant, 
n is the number of binding sites expressed by DNA base pairs.  
 
2.4.3. Viscometric study 
In order to understand the mode of DNA complex interaction – intercalation or groove binding – a 
viscometric study was carried out as the most authentic test [23]. Viscosity measurements were 
carried out with a micro viscometer (Model Brookfield DVII+pro-v6.3) attached to a water-bath at 
30
o
C. The viscosity of DNA in absence of any complex was first quantitated, followed by the 
measurements after addition of increasing concentration of compounds (II, III and IV) into the 
DNA up to its saturation separately. After each addition of complex, 1.5 min was allowed to attain 
thermal equilibrium and then the viscosity was measured individually. The viscometric data was 
calculated maintaining viscometric rotor stirring at 100  rpm and each measurement was repeated 
three times in order to find out the average of value. The data were plotted as (η/η0)1/3 versus r, 
where η and η0 signified the viscosity of DNA in the presence and absence of complex 
respectively and r represented the molar ratio of complex: DNA. 
 
 
3.     Result and Discussion  
3.1. Crystal structures of H2MHyP (I), [Co(HMHyP)2]Cl (II), [Co(HMHyP)2]Br (III) and    
[Cu(HMHyP)]NO3 (IV) 
  
The molar conductance values in MeOH (30
o
C) indicate 1:1 electrolytic character of the 
complexes [24] and conform to the general compositions, [Co(HMHyP)2]Cl  (X= Cl and Br) and 
[Cu(HMHyP)]NO3.  
Views of the X-ray structures of the free ligand (H2MHyP) (I), and its metal complexes-                
[Co(HMHyP)2]Cl (II), [Co(HMHyP)2]Br (III) and [Cu(HMHyP)]NO3 (IV) with atom numbering 
scheme are shown in Figs 2, 3, 4 and 5, respectively. The crystallographic data and refinement 
parameters are summarized in Table 1. The structure of the primary ligand molecule I has an 
asymmetric unit comprising an H2MHyP molecule and a molecule of water of crystallization. The 
structures of complexes II to IV have asymmetric units comprising a molecule of mononuclear 
metal complex, anion and solvent of crystallization. Some selected bond distances and bond angles 
of four structures are compiled and compared in Table 2. The structure of ligand (I) (Fig. 2) shows 
that the neutral ONN tridentate ligand has a planar arrangement, with O1 and N4 positioned to 
interact via an O–H···N hydrogen bond, and with the N3–N4 bond oriented to minimize steric 
interactions between the pyrimidyl and N-methyl groups. The structures of compounds II and III 
show that they adopt related distorted octahedral geometries, (Figs 3 & 4, respectively). In both 
cases the Co(III) centers are coordinated in a N4O2 fashion by two mono-deprotonated ligands, 
using pairs of cis pyrimidyl-N, trans-azomethine-N and cis- hydroxyl-O atoms. The two pyrimidyl 
nitrogen atoms (N1 and N5) and two hydroxyl oxygen atoms (O1 and O3) are located in the square 
plane, with the two azomethine nitrogen atoms  (N4 and N8) occupying the axial positions, both 
ligands binding in meridional fashion, and retaining a degree of planarity. One of the two ligands 
in complex II appears to be showing a tautomeric form. Its C1–N2 bond distance [1.372(3) Å] is 
longer than those observed for free ligand [1.3427(14) Å]; additionally, the C1-N3 bond [1.302(3) 
Å] is correspondingly shorter than the equivalent bond in the free ligand [1.3675(15) Å]. These 
  
changes in bond distances, combined with the inability to locate a hydrogen atom on N3 of one 
ligand, instead finding it at N2, is indicative of the presence of double bond character for the C1-
N3 bond, and single bond character for the C1-N2 bond. No such significant bond shortening is 
observed in either the second ligand of complex II or in complexes III and IV. The structure of 
compound IV (Fig. 5) shows it adopting a distorted square-planar geometry. The Cu(II) centre is 
coordinated in an N2O2 fashion by a mono-deprotonated ligand, using pyrimidyl-N, azomethine-N, 
hydroxyl-O, as well as a coordinated water molecule. The deviation of Cu
2+
 from the square plane 
is 0.0162(13) Å. 
 Table 3 gives the details of the hydrogen bonding interactions of the four reported compounds. 
Each molecule of compound I is connected via two O–H···O hydrogen bonds to adjacent water 
molecules, forming one-dimensional zigzag chains running along the crystallographic c-axis. 
These chains are connected into 2D sheets in the ac plane by further O–H···N hydrogen bonds 
between the water and one pyrimidine nitrogen (Fig. 6). In compound II, each molecule of the 
complex is connected via two O–H···Cl and one Npyrimidyl–H···Cl hydrogen bonds to three adjacent 
chloride anions, and via one Nhydrazinyl–H···O hydrogen bond to the adjacent water molecule.  Each 
chloride in turn is a total of four hydrogen-bonding interactions, two hydroxyl-OH, one pyrimidyl-
NH and one water-OH, while the water molecule acts as donor for two hydrogen bonds, one to 
chloride, the other to one hydroxyl-O.  This arrangement of interactions results in the formation of 
a topologically complex three-dimensional hydrogen-bonded network (Fig. 7).  In contrast to 
compound II, showing no hydrogen bonds between adjacent complexes, compound III forms one-
dimensional hydrogen-bonded chains propagating along the a-axis via O–H···O interactions 
between O2 and O4.  These chains are linked into two-dimensional sheets in the ac plane by two 
O–H···Br (one from the complex, the other from EtOH), one N–H···Br and one N–H···O 
  
hydrogens bonds (Fig. 8). In compound IV each complex is connected to an adjacent complex by 
O-H···O hydrogen bonds between the coordinated water and two bridging nitrate anions, forming 
a dinuclear hydrogen-bonded complex.  These complexes are linked together by N–H···O 
hydrogen bonds to form a double-layer zigzag chain running along the ab-diagonal axis.  The two 
water molecules are found to hydrogen bond at the periphery of this chain.  Due to the inability to 
locate hydrogen atoms on one water it is difficult to determine what forth hydrogen-bonding 
interactions would arise from it, however its positioning suggests that the two water molecules 
could be involved in interactions linking adjacent (Fig. 9).  
3.2.   DNA Interaction Studies 
3.2.1. Stability of the complexes in solution 
The solution spectrum (in DMSO) of each reported complex species is similar in nature with the 
spectrum obtained in solid state (DRS), indicating no gross electronic or geometric change occurs 
on dissolution of the complex in the solvent; the HRMS studies of all the compounds in methanol 
showed satisfactory result in each case (data included in the text). Moreover, the stability of the 
complex species in solution has been studied by taking UV-Vis spectra of each complex species 
immediately after dissolution in the said solvent (zero hr) and after 48 hrs of incubation at RT. It 
has been observed that in each case the spectral nature is grossly similar (Figs. S1-S3), indicating 
the retention of structure in solution. 
 
3.2.2. UV-Visible spectroscopic study 
The absorbance at 260 nm of ST DNA in the presence of 50 mM Tris Buffer decreased gradually 
with the increment of the each complex concentration and there was a sign of interaction between 
compounds with respect to DNA Fig.10(a)-(c).  The binding isotherm of DNA–complex 
  
interaction (not shown) represented sigmoidal nature of interaction indicating cooperative nature of 
DNA complex bindings. Form the derived log plot by Figs 12(a), 13(a) and 14(a), both the binding 
constant as well as Y could be calculated. The binding constant (K) for each case has been 
calculated and found to be 16.9 x 10
3 
M
-1
, 19.9 x 10
3
 M
-1
 and 16.4 x 10
3
 M
-1 
for the compounds II, 
III and IV, respectively. The Y value of the also was determined from the slope of the straight line 
which was found to be 4.4, 3.1 and 3 respectively for the compounds II, III and IV. The positive 
sign of the Y indicated that the interaction was highly co-operative. 
 
3.2.1.   Fluorescence quenching of EB–DNA by compound II, III & IV  
Ethidium bromide (EB) can be used as the fluorescence probe for DNA to study the molecular 
interactions between DNA and the compounds in the excited state. Though EB is a moderate 
fluorophore, but in presence of DNA it provides powerful fluorescence maximum at 600 nm on 
excitation at 480nm due its strong binding power with two nucleotide base pairs in intercalated 
state. The enhanced fluorescence of EB-DNA can be reduced by the addition of another interacting 
molecule [25, 26]. In the present systems, we have studied the effects of pyrimidine containing 
Schiff base ligand (I) and its metal compounds (II, III and IV) on the DNA through fluorescence 
emission spectral studies. Compound I didn’t show any fluorescence emission on interaction with 
EB-DNA.  [Fig. 11(a)-(c)]. It has been observed that the addition of compounds II- IV (suspended 
in DMSO solution) to a solution of EB bound DNA resulted in a decrease in fluorescence emission 
intensity in each case, which may be due to  the quenching of fluorescence takes place upon 
interaction between DNA and metal compounds. The fluorescence quenching is quantitated by the 
Stern–Volmer relation: 
                                       F0 /F = 1+ Ksv[Q] …………...[3] 
  
Where, F0 and F are the emission intensities of the fluorophore in absence and in presence of 
quencher, respectively. Ksv is the stern-volmer (SV) constant [27]. [Q] is the concentration of the 
interacting molecule i.e.; quencher. According to equation (1), we obtained a linear plot for F0/F 
against each quencher [Figs. 12(b), 13(b) and 14(b)]. From the slopes of the straight line, we have 
calculated the SV constants for the quenchers  (KSV = 2.9 x 10
3
 for II, 3 x 10
3 
for III and 1 x 10
3 
M 
-1 
for IV).  
Moreover the relation of Ksv with Kq is Ksv=Kq X Γ where, Kq and Γ were quenching constant and 
the lifetime of flour, respectively [28]. The value of Kq determined the nature of quenching, as the 
higher value than the limiting value (limiting value of 1 X 10
10
 M
-1
s
-1
) denoted the static 
quenching whereas, the lower value denoted the dynamic ones. It was reported that the Γ value for 
DNA-EB was in the range of 23 ns [27]. Thus the observed Kq found to be 12.6 X 10
10
 M
-1
s
-1
, 
13.04 X 10
10
 M
-1
s
-1
 and 4.31 X 10
10
 M
-1
s
-1 
for the compounds II, III and IV, respectively.  The 
obtained bimolecular quenching constant (kq) was much larger than the limiting value of 1 X 10
10
 
M
-1
s
-1
, which was considered the maximum positive value in fluorescence quenching in aqueous 
conditions. Thus dynamic quenching may be cancelled for the quenching of EB–DNA 
fluorescence by each of the compound. 
The binding constant (K) for each case has been calculated according to the Scatchard equation as 
mention above and found to be 13.2 X 10
3 
M
-1
, 19.9 X 10
3
 M
-1
 and 12.8 X 10
3
 M
-1 
for the 
compounds II, III and IV, respectively [Figs 12(c), 13(c) and 14(c),]. The numbers of binding 
sites (n) are obtained as 2.15, 1.56 and 3.57 for II, III and IV, respectively. The values of ‘‘n” was 
found to be in the range of 2-4 and existence of multiple binding sites in DNA for all the 
compounds. The more than one binding sites was also supported nature of co-operative 
interactions at ground states observed in UV-Visible study. That In general the pyrimidine ring 
  
structure somehow replaced the EB and might be intercalated between base pairs, thereby, 
repelling the EB from the said position causing decrease in fluorescence intensity. The binding 
constant of these two types of compounds (both octahedral Co(III) and square planner Cu(II)) are 
of the same order. Actually DNA ligand interaction solely depend not only the architecture of the 
DNA but also of ligand structure. As both ligands of these two compounds remained same thereby 
there are some common strategies to replace the bound EB from the DNA or quenching the 
fluorescence of the DNA-EB compounds by metal upon complexation. The latter is true as EB-
DNA interaction are stronger than the DNA ligand interactions (almost comparable), thus the 
quenching process are carried out by metal compounds (the contribution of the free ligand DNA 
interaction is minimum (data not shown). Thus the both compounds would have almost same range 
of binding strength.  
 
3.2.3. Viscometric study 
Hydrodynamic method, such as changes in viscosity, which is exquisitely dependent to the change 
of length of DNA, may be the most effective means studying the binding mode of compounds to 
DNA. To confirm the interaction mode of the complex with DNA, a viscosity study was 
performed. Groove-binding typically resulted in only a few changes in structure in the backbone 
keeping the DNA essentially in an unaltered in naturally B-form, whereas intercalation resulted in 
an increase in the length DNA structure due to insertion of planar ligand moiety between adjacent 
base pairs [23, 29]. Thus intercalation of compound inside the DNA base pairs caused lengthening, 
stiffening and unwinding of the helix resulting with a pronounced increment of the intrinsic 
viscosity. Thus increase in viscosity signified intercalation mode of interaction rather than groove 
binding ones. Our preliminary study showed that gradual increase of viscosity with the rise of 
  
compound concentrations [Figs 12(d), 13(d) and 14(d)]. This increase in viscosity proved that all 
of the metal compounds intercalated inside the DNA base pairs. 
 
4.   Conclusion 
The present communication provides a general and effective method for the synthesis of 2,4-
dihydroxyacetophenone-4,6-dimethylhydrazino pyrimidine, H2MHyP and its Co(III) and Cu(II) 
complexes. All the compounds are monomeric in nature and crystallize in either monoclinic (I & 
III) or triclinic (II & IV) crystal system; with nearly octahedral and square planar geometries for 
Co(III) and Cu(II) complexes, respectively. Compounds II, III & IV show potential DNA binding 
activities with Salmon Testis DNA due to their positive metal Centre’s. The order of association 
constant all of the compounds are in the range of 10
4 
M
-1
 at both ground and excited states which is 
quite high. The nature of quenching is static with an intercalation mode of bindings in all the 
synthesized compounds. 
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Appendix A. Supplementary material 
Crystallographic data for the structures reported here have been deposited with the Cambridge 
Crystallographic Data Center, CCDC Nos 1015148, 1015149, 1015150 and 1015151. Copies of 
this information may be obtained free of charge from the Director, CCDC, 12 Union Road, 
Cambridge, CB2 1EZ, UK (Fax: +44-1223-336-033); E-mail: deposit@ccdc.cam.ac.uk or 
http://www.ccdc.cam.ac.uk. Figures S1-S3 are available as supplementary materials. 
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Figure captions 
Figure 1.  Structural Formulation of the ligand (H2MHyP). 
Figure 2.  View of the asymmetric unit (crystallographic numbering) of I. Thermal ellipsoids                     
                  are drawn at the 50 % probability level. 
 
Figure 3. View of the asymmetric unit (crystallographic numbering) of II. Thermal ellipsoids     
                  are drawn at the 50 % probability level. 
 
Figure 4.  View of the asymmetric unit (crystallographic numbering) of III. Thermal  
                  ellipsoids are drawn at the 50 % probability level. 
 
Figure 5.  View of the asymmetric unit (crystallographic numbering) of IV. Thermal  
                  ellipsoids are drawn at the 50 % probability level. 
 
Figure 6.  Views of the two-dimensional hydrogen-bonded sheet formed by I. Hydrogen    
                  atoms not involved in hydrogen bonding are omitted. (top) View down the b-axis  
                  of the sheet in the ac-plane. (Bottom) View down the a-axis of two adjacent    
                  corrugated sheets. 
 
Figure 7.  View down the c-axis of the three-dimensional hydrogen-bonded network formed  
                  by II. Hydrogen atoms not involved in hydrogen bonding are omitted. 
 
Figure 8.  Views of the two-dimensional hydrogen-bonded sheet formed by III. Hydrogen  
                  atoms not involved in hydrogen bonding are omitted. (top) View down the b-axis  
                  of the sheet in the ac-plane. (bottom) View down the a-axis of corrugated sheet. 
 
Figure 9.  View down the ac-diagonal axis of the one-dimensional hydrogen bonded double- 
                  layered chains formed by IV, running along the ab-diagonal axis  Hydrogen atoms  
                  not involved in hydrogen bonding are omitted. 
 
 
Figure 10. UV-Vis. Absorption titration of Salmon Testis-DNA in the presence of various  
                   concentrations   
                   (a) compound II ([comp. II] = 0-160 µM);  
                   (b) compound III ([comp. III] = 0-125 µM);  
                   (c) compound IV ([comp. IV] = 0-160 µM). 
 
 
 
  
Figure 11.  Fluorescence quenching of EB–DNA in the presence of various concentrations  
                   (a) compound II( λmax= 480 nm; λemi= 600 nm; [comp. II] = 0-600 µM); 
                   (b) compound III( λmax= 480 nm; λemi= 600 nm; [comp. III] = 0-600 µM); 
                   (c) compound IV( λmax= 480 nm; λemi= 600 nm; [comp. IV] = 0-1050 µM). 
  
 
 
Figure 12. (a) Hill plot of  compound II ([comp. II]= 0-160 µM) with DNA interaction;  
                  (b) Stern-Volmer plot of DNA-EtBr with compound  II ( λmax= 480 nm; λemi= 600   
                  nm; [comp. II] = 0-530 µM); (c) Derived Scatchard plot of  compound II in the  
                  excited state range; (d) Viscometric  study of compound II with DNA (keeping  
                  DNA conc. 300 µM with a gradual addition of varying conc. of compound II with  
                 a maximum ratio of 0.5). 
 
 
Figure 13. (a) Hill plot of compound III ([comp. III]= 0-125 µM) with DNA interaction;  
                  (b) Stern-Volmer plot of DNA-EtBr with compound  III ( λmax= 480 nm;  
                    λemi= 600 nm; [comp. III] = 0-600 µM); (c) Derived Scatchard plot of    
                   compound III in the excited state range; (d) Viscometric  study of compound III   
                   with DNA (keeping DNA conc. 300 µM with a gradual addition of varying conc.   
                   of compd. III with a maximum ratio of 0.7). 
 
Figure 14.  (a) Hill plot of  compound IV ([comp. IV]= 0-160 µM) with DNA interaction;  
                   (b) Stern-Volmer plot of DNA-EtBr with compound  IV ( λmax= 480 nm; λemi=  
                    600 nm; [comp. IV] = 0-1050 µM); (c) Derived Scatchard plot of  compound III          
                   in the excited state range; (d) Viscometric  study of compound IV with DNA  
                  (keeping DNA conc. 300 µM with a gradual addition of varying conc. of compd.  
                   IV with a maximum ratio of 1.3). 
 
Figure S1. (a) Solid state UV-Vis spectra (DRS) of compound II; (b) UV-Vis spectra of   
                  compound II (200-400nm) in DMSO; (c) UV-Vis spectra of compound II (400-    
                   900nm) in DMSO. 
 
 Figure S2. (a) Solid state UV-Vis. spectra (DRS) of compound III; (b) UV-Vis spectra of  
                   compound III (200-400nm) in DMSO; (c) UV-Vis spectra of Compound III      
                   (400-900nm) in DMSO. 
 
Figure S3. (a) Solid state UV-Vis. spectra (DRS) of compound IV; (b) UV-Vis spectra of  
                  compound IV (200-400nm) in DMSO; (c) UV-Vis spectra of compound IV           
                  (400-900nm) in DMSO. 
  
 
  
Table 1. Crystal data and structure refinement parameters for C14H18N4O3 (I), C28H32ClCoN8O5 (II),  
C30H36BrCoN8O5 (III), and C14H21CuN5O8 (IV)    
Crystal data                                          I                                 II                                       III                                      IV             
Empirical Formula                      C14H18N4O3             C28H32ClCoN8O5               
C30H36BrCoN8O5               C14H21CuN5O8  
Formula Weight                              290.32                        655.00                                727.50                                450.89 
Crystal System                    Monoclinic                  Triclinic                            Monoclinic                           Triclinic 
Space Group                                P21/c (#14)                  P-1 (#2)                           P21/n (#14)                            P-1 (#2) 
Temperature (K)                             173                             173                                      173                                      173 
Wavelength (Å)                           0.71075                      0.71075                               0.71075                           0.71075 
   a [Å]                                    8.8142(10)                9.9443(15))                        11.4355(9)                         6.9710(9)  
  b [Å]                                         11.5377(14)              12.5537(18)                      15.3368(14)                         9.7780(12)  
  c [Å]                            14.2644(17)           12.617(2)                    18.3422(18)                    13.8111(18) 
   α [o]                                             90                          105.014(3                             90                                     99.403(3) 
   β [o]                                91.215(4)                      91.543(3)                        104.116(3)                          99.091(2) 
[o]                                              90                             105.753(3)                       90                             101.985(3)   
 Volume [Å3]                           1450.3(3)                      1456.1(4)                      3119.8(5)                               890.4(2) 
 Z, Dcalc. [gm/cm
3
]                    4, 1.330                        2, 1.494                        4, 1.549                           2, 1.682                                                                                   
F (000)                                           616                                680                                  1496                                    466 
Crystal size [mm]                  0.27X 0.10 X 0.06         0.10X 0.03 X 0.02            0.22 X 0.10 X 0.06         0.11X0.07 X0.02 
θ ranges (°)                                   2.27 to 25.37                  1.68 to 25.43   1.75 to 25.42                   1.53 to 25.42 
Limiting indices                         -10 <= h <= 10             -12 <= h <= 12               -13 <= h <= 13                -8 <= h <= 8                 
                                                    -13 <= k <= 13            -15 <= k <= 15               -18 <= k <= 18                -11 <= k <= 11                   
                                                    -17 <= l <= 16             -15<= l <= 15                  -22 <= l <= 22               - 16 <= l <= 16   
Reflections collected                           17364                         17997                        37604                               11039  
Unique reflections                  2663 [R(int) = 0.0400]     5321 [R(int) = 0.0507]     5737 [R(int) = 0.0305]       3246[R(int)=0.0429]   
Refinement method                      Full-matrix least              Full-matrix least              Full-matrix least           Full-matrix least 
                                                      -Squares on F2                      -Squares on F2                         -Squares on F2                        -Squares on F2 
   Data / parameters                            2663/ 208                        5321/ 418            5737/ 433                      3246 / 276                        
  Goodness-of-fit on F2                        1.086                                0.977                1.061                               1.064 
Final R indices [I>2σ (I)]             R1= 0.0383                           R1= 0.0312        R1 = 0.0286                      R1= 0.0550           
R indices (all data)                        R1 =0.0427                          R1 =0.0360        R1 = 0.0314                      R1 =0.0594                    
                                                    wR2 =0.1164                         wR2 =0.0837        wR2 = 0.0824                  wR2 =0.1474                                                    
Min. and Max. Resd. Dens.[e/ Å3]   -0.20 and 0.24                -0.33 and 0.40      -0.38 and 0.90                  -1.44 and 1.59 
 
 
  
Table 2. Selected bond lengths (Å), bond angles and torsion angles (º) of C14H18N4O3 (I), C28H32ClCoN8O5 (II),  
C30H36BrCoN8O5 (III)  and C14H21CuN5O8 (IV)    
 
                                       I                                           II                                  III                                                 IV 
                                                                               
Bond lengths                                                               
N1–C1                  1.3393(14)                                   1.384(2)                          1.353(3)                                  1.347(5)                             
N5-C15                      -                                              1.357(2)                          1.355(3)                                        -      
N2-C1               1.3427(14)                                  1.372(3)                          1.329(3)                                  1.339(5) 
N6-C15                      -                                              1.332(2)                          1.327(3)                                         - 
N1–C2                  1.3379(15)                                   1.335(3)                          1.363(3)                                  1.368(6) 
N5-C16                     -                                               1.357(3)                          1.360(2)                                          - 
N3–C1                  1.3675(15)                                   1.302(3)                          1.369(2)                                  1.365(6) 
N7–C15                    -                                               1.352(3)                          1.363(2)                                         - 
N3–N4                 1.3631(14)                                    1.396(2)                          1.391(3)                                  1.383(4) 
N7–N8                      -                                               1.3901(19)                      1.398(3)                                        - 
N4–C5                 1.2895(15)                                    1.307(2)                          1.305(2)                                   1.306(6) 
N8–C19                      -                                             1.299(3)                           1.299(2)                                         - 
O1–C8                  1.3646(14)                                   1.326(2)                          1.323(2)                                    1.314(6) 
 O3–C22                    -                                              1.316(2)                           1.315(2)                                         - 
M1–N1                      -                                              1.9791(19)                       1.9869(18)                               2.010(3) 
M1–N5                      -                                              2.0007(15)                       1.9701(18)                                       - 
M1–N4                      -                                              1.8791(14)                       1.8978(17)                               1.932(4) 
M1–N8                      -                                              1.8893(14)                       1.8968(17)                                       - 
M1–O1                      -                                              1.8476(15)                       1.8656(15)                               1.873(3)    
 M1–O3                     -                                              1.8574(12)                       1.8755(14)                                        - 
M1–O3(W)                -                                                      -                                    -                                          1.975(3)             
 
Bond angles  
                                            
C1-N1-C2            115.62(10)               117.98(18)                        116.08(18)                             115.7(3)                 
N4-N3-C1            118.05(9)                                     109.46(15)                        114.83(17)                              116.8(3) 
N3-N4-C5           122.46(9)                                 116.71(15)                      118.12(17)                           117.7(3) 
N1-C1-N2            127.16(10)                      119.30(18)                         127.28(18)                             127.6(4) 
N2-C1-N3           115.12(9)                                 118.08(17)                      115.22(19)                           114.6(4)  
N1-C1-N3           117.72(10)                               122.62(18) 117.45(19)                         117.7(3) 
N4-C5-C7            114.83(9)                                     119.55(16)                        119.10(19)                              120.1(4) 
C5–C7–C8           122.07(10)                                   122.64(16)                        121.17(17)                             124.0(4) 
O1-C8-C7            122.40(10)                                   124.37(19)                        123.6(2)                                 124.5(3) 
C7-C8-C9            120.95(10)                                   119.68(17)                        119.45(17)                              118.7(4)  
N1-M1-N4              -                                                81.45(7)                             83.09(7)                                 83.17(14) 
N5-M1-N8             -                                           81.52(6)                          83.26(7)                                       - 
O1-M1-N4              -                                                92.86(7)                             90.59(7)                                 92.39(13)  
O3-M1-N8              -                                                91.45(6)                        92.31(7)                                       -  
 N1-M1-N8             -                                                97.13(7)                        102.76(7)                                     - 
 N1-M1-N5            -                                                 86.51(7)                        96.70(7)                                       - 
 N4-M1-N5            -                                                 96.91(6)                             99.13(7)                                       - 
N4-M1-N8             -                                                 177.97(6)                      173.44(7)                                     -  
O1-M1-N8             -                                                 88.47(7)                        83.40(7)                                       - 
O3-M1-N4             -                                                 90.03(6)                        84.95(6)                               175.18(14) 
O1-M1-N1              -                                                173.64(7)                      172.95(7)                        173.13(14) 
O1-M1-N5              -                                                91.37(7)                        87.36(7)                                       - 
 O3-M1-N1             -                                                91.00(6)                        87.25(7)                                       - 
O3-M1-N5              -                                                172.19(6)                      174.62(7)                                      - 
O1-M1-O3              -                                                91.86(6)                        89.08(6)                                       - 
 
 
 
  
Table 3. Hydrogen bonding distances (Å) and angles ( ◦) 
                                                                     
D-H···A                                   D-A(Å)             D-H(Å)                    H···A(Å)               <D-H···A(◦)               symmetry 
                                                                         Compound 1 
O1-H1···N1 (intramol )      3.3406(13)          0.965(16)             2.567(17)           137.3(15)                        -         
 O1-H1···N4 (intramol.)     2.5226(12)   0.965(16)      1.645(16)             149.0(17)                        -   
O2-H2··· O21        2.6814(14)   0.934(17)       1.764(17)             166.7(17)            X+1, Y+1/2, Z+1/2-1  
 O21-H21A···O1        2.7855(12)   0.930(15)       1.873(15)             166.6(15)            X-1, Y, Z 
O21-H21B···N2        2.7840(13)   0.944(16)       1.961(17)             144.5(14)                        -               
 N3-H3···O21        2.9859(14)    0.912(13)       2.222(13)             140.9(12)                        - 
                                                                       Compound II 
O2-H2···Cl1                    3.0229(15)   0.904(17)        2.121(18)             176(3)                X, Y, Z+1    
 O4-H4···Cl1      3.0350(16)   0.929(16)        2.120(17)              168(2)              -X+1,-Y+1,-Z+1 
 O31- H31A··· Cl1      3.190(2)   0.940(17)        2.273(18)              165(2)                         - 
 O31-H31B··· O2      2.905(2)   0.951(18)        1.98(2)                  163(3)              -X+1,-Y,-Z+1  
 N2-H2A···Cl1      3.159(2)   0.948(17)        2.267(19)              156(2)                      -  
 N7-H7···O31      2.805(2)   0.923(16)        1.897(17)              167(2)              X-1, Y, Z 
                                                                        Compound III 
O2-H2···O4      2.756(3)    0.934(17)       1.831(18)                 171(3)             X-1, Y, Z  
 O4-H4···Br1      3.1614(16)    0.936(18)       2.24(2)                     167(3)           -X+2, -Y, -Z+2 
 O31-H31···Br1      3.241(2)    0.945(17)       2.340(19)                159(2)        -X+1/2+1, Y+1/2, -Z+1/2+1   
 N3-H3···O31     2.760(3)    0.932(17)      1.864(18)                 160(2)                    - 
  N7-H7···Br1     3.4703(18)    0.952(17)      2.57(2)                     158(2)         -X+1, -Y, -Z+2  
                                                                      Compound IV 
 O2-H2···O31      2.685(7)    0.96(2)        1.74(2)                   170(6)          X, Y-1, Z 
 O3-H3B···O21      3.191(11)    0.96(2)        2.37(4)                   143(5)         X, Y-1, Z 
 O3-H3B···O23      2.998(8)    0.96(2)        2.07(3)                   163(5)         X, Y-1, Z 
 O3-H3C···O21      2.725(5)     0.96(2)        1.84(3)                   153(6)        -X+1, -Y, -Z+1 
 O31-H31A···O23      3.004(10)     0.97(2)        2.03(3)                   173(11)     -X+1, -Y+1, -Z+1 
O31- H31B···O41      3.36(3)                      0.98(2)        2.51(8)                   144(10)      -X, -Y+1, -Z+1 
 N3-H3A···O22     2.965(6)     0.96(2)       2.07(3)                   156(4)          X+1, Y, Z  
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A new pyrimidine based Schiff base ligand and its Co(III) & Cu(II) complexes have been 
synthesized. The structural conformations of Co(III) and Cu(II) complexes have been established 
by X-ray studies and the detailed DNA binding activities and mode of DNA binding with metal 
complexes have been reported.  
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